Foto del docente

Michele Cavo

Full Professor

Department of Medical and Surgical Sciences

Academic discipline: MED/15 Blood Diseases

Head of SCUOLA DI SPECIALIZZAZIONE IN EMATOLOGIA (D.I. 68/2015)

Publications

Mateos, Maria Victoria; Weisel, Katja; Terpos, Evangelos; Delimpasi, Sossana; Kastritis, Efstathios; Zamagni, Elena; Delforge, Michel; Ocio, Enrique; Katodritou, Eirini; Gay, Francesca; Larocca, Alessandra; Leleu, Xavier; Otero, Paula Rodriguez; Schjesvold, Fredik; Cavo, Michele; Dimopoulos, Meletios A., Belantamab mafodotin: an important treatment option for vulnerable patients with triple class exposed relapsed and/or refractory multiple myeloma, «HAEMATOLOGICA», 2024, 0, pp. 0 - 0 [Scientific article]

Pensato V.; Laginestra M.A.; Falvo P.; Orecchioni S.; Talarico G.; De Marchi E.; Bruno S.; Mongiorgi S.; Mitola G.; Bertolini F.; Adinolfi E.; Cavo M.; Curti A.; Salvestrini V., Bitter Taste Receptor Agonist Denatonium Inhibits Stemness Characteristics in Hematopoietic Stem/Progenitor Cells, «STEM CELLS», 2024, 42, pp. 42 - 54 [Scientific article]

Sonneveld P.; Dimopoulos M.A.; Boccadoro M.; Quach H.; Ho P.J.; Beksac M.; Hulin C.; Antonioli E.; Leleu X.; Mangiacavalli S.; Perrot A.; Cavo M.; Belotti A.; Broijl A.; Gay F.; Mina R.; Nijhof I.S.; Van De Donk N.W.C.J.; Katodritou E.; Schjesvold F.; Sureda Balari A.; Rosiñol L.; Delforge M.; Roeloffzen W.; Silzle T.; Vangsted A.; Einsele H.; Spencer A.; Hajek R.; Jurczyszyn A.; Lonergan S.; Ahmadi T.; Liu Y.; Wang J.; Vieyra D.; Van Brummelen E.M.J.; Vanquickelberghe V.; Sitthi-Amorn A.; De Boer C.J.; Carson R.; Rodriguez-Otero P.; Bladé J.; Moreau P., Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone for Multiple Myeloma, «THE NEW ENGLAND JOURNAL OF MEDICINE», 2024, 390, pp. 301 - 313 [Scientific article]

Sparano F.; Giesinger J.M.; Gaidano G.; Anota A.; Cavo M.; Brini A.; Voso M.T.; Venditti A.; Perrone F.; Di Maio M.; Luppi M.; Baron F.; Platzbecker U.; Fazi P.; Vignetti M.; Efficace F., Financial Toxicity and Health-Related Quality of Life Profile of Patients With Hematologic Malignancies Treated in a Universal Health Care System, «JCO ONCOLOGY PRACTICE», 2024, 20, pp. 438 - 447 [Scientific article]

Delforge M.; Patel K.; Eliason L.; Dhanda D.; Shi L.; Guo S.; Marshall T.S.; Arnulf B.; Cavo M.; Nooka A.; Manier S.; Callander N.; Giralt S.; Einsele H.; Ailawadhi S.; Popa McKiver M.; Cook M.; Rodriguez-Otero P., Health-related quality of life in patients with triple-class exposed relapsed and refractory multiple myeloma treated with idecabtagene vicleucel or standard regimens: patient-reported outcomes from the phase 3, randomised, open-label KarMMa-3 clinical trial, «THE LANCET. HAEMATOLOGY», 2024, 11, pp. 216 - 227 [Scientific article]

Mateos M.-V.; Engelhardt M.; Leleu X.; Mesa M.G.; Cavo M.; Dimopoulos M.; Bianco M.; Merlo G.M.; Porte C.L.; Richardson P.G.; Moreau P., Impact of prior treatment on selinexor, bortezomib, dexamethasone outcomes in patients with relapsed/refractory multiple myeloma: Extended follow-up subgroup analysis of the BOSTON trial, «EUROPEAN JOURNAL OF HAEMATOLOGY», 2024, 0, pp. 0 - 0 [Scientific article]

Palandri F.; Palumbo G.A.; Benevolo G.; Iurlo A.; Elli E.M.; Abruzzese E.; Polverelli N.; Tiribelli M.; Auteri G.; Tieghi A.; Caocci G.; Binotto G.; Cavazzini F.; Branzanti F.; Beggiato E.; Miglino M.; Bosi C.; Crugnola M.; Bocchia M.; Martino B.; Pugliese N.; Scaffidi L.; Venturi M.; Duminuco A.; Isidori A.; Cattaneo D.; Krampera M.; Pane F.; Cilloni D.; Semenzato G.; Lemoli R.M.; Cuneo A.; Trawinska M.M.; Vianelli N.; Cavo M.; Bonifacio M.; Breccia M., Incidence of blast phase in myelofibrosis patients according to anemia severity at ruxolitinib start and during therapy, «CANCER», 2024, 130, pp. 1270 - 1280 [Scientific article]Open Access

Rodriguez-Otero, Paula; Usmani, Saad; Cohen, Adam D; van de Donk, Niels W C J; Leleu, Xavier; Pérez-Larraya, Jaime Gállego; Manier, Salomon; Nooka, Ajay K; Mateos, Maria Victoria; Einsele, Hermann; Minnema, Monique; Cavo, Michele; Derman, Benjamin A; Puig, Noemi; Gay, Francesca; Ho, P Joy; Chng, Wee-Joo; Kastritis, Efstathios; Gahrton, Gösta; Weisel, Katja; Nagarajan, Chandramouli; Schjesvold, Fredik; Mikhael, Joseph; Costa, Luciano; Raje, Noopur S; Zamagni, Elena; Hájek, Roman; Weinhold, Niels; Yong, Kwee; Ye, Jing Christine; Sidhana, Surbhi; Merlini, Giampaolo; Martin, Tom; Lin, Yi; Chari, Ajai; Popat, Rakesh; Kaufman, Jonathan L, International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma, «THE LANCET ONCOLOGY», 2024, 25, pp. 0 - 0 [Scientific article]

Richardson, Paul G.; Perrot, Aurore; Miguel, Jesus San; Beksac, Meral; Spicka, Ivan; Leleu, Xavier; Schjesvold, Fredrik; Moreau, Philippe; Dimopoulos, Meletios A.; Huang, Shang-Yi; Minarik, Jiri; Cavo, Michele; Prince, H. Miles; Macé, Sandrine; Zhang, Rick; Dubin, Franck; Morisse, Mony Chenda; Anderson, Kenneth C., Isatuximab-pomalidomide-dexamethasone versus pomalidomide-dexamethasone in patients with relapsed and refractory multiple myeloma: final overall survival analysis, «HAEMATOLOGICA», 2024, 0, pp. 0 - 0 [Scientific article]

Terragna C.; Poletti A.; Solli V.; Martello M.; Zamagni E.; Pantani L.; Borsi E.; Vigliotta I.; Mazzocchetti G.; Armuzzi S.; Taurisano B.; Testoni N.; Marzocchi G.; Kanapari A.; Pistis I.; Tacchetti P.; Mancuso K.; Rocchi S.; Rizzello I.; Cavo M., Multi-dimensional scaling techniques unveiled gain1q&loss13q co-occurrence in Multiple Myeloma patients with specific genomic, transcriptional and adverse clinical features, «NATURE COMMUNICATIONS», 2024, 15, Article number: 1551 , pp. 1551 - 1551 [Scientific article]

Rodriguez-Otero, Paula; Ailawadhi, Sikander; Arnulf, Bertrand; Patel, Krina; Cavo, Michele; Nooka, Ajay K; Manier, Salomon; Callander, Natalie; Costa, Luciano J; Vij, Ravi; Bahlis, Nizar J; Moreau, Philippe; Solomon, Scott R; Delforge, Michel; Berdeja, Jesus; Truppel-Hartmann, Anna; Yang, Zhihong; Favre-Kontula, Linda; Wu, Fan; Piasecki, Julia; Cook, Mark; Giralt, Sergio, Plain Language Summary of the KarMMa-3 study of ide-cel or standard of care regimens in people with relapsed or refractory multiple myeloma, «FUTURE ONCOLOGY», 2024, 0, pp. 0 - 0 [Scientific article]

Mai E.K.; Hielscher T.; Bertsch U.; Salwender H.J.; Zweegman S.; Raab M.S.; Munder M.; Pantani L.; Mancuso K.; Brossart P.; Beksac M.; Blau I.W.; Durig J.; Besemer B.; Fenk R.; Reimer P.; van der Holt B.; Hanel M.; von Metzler I.; Graeven U.; Muller-Tidow C.; Boccadoro M.; Scheid C.; Dimopoulos M.A.; Hillengass J.; Weisel K.C.; Cavo M.; Sonneveld P.; Goldschmidt H., Predictors of early morbidity and mortality in newly diagnosed multiple myeloma: data from five randomized, controlled, phase III trials in 3700 patients, «LEUKEMIA», 2024, 38, pp. 640 - 647 [Scientific article]Open Access

Palandri F.; Auteri G.; Abruzzese E.; Caocci G.; Bonifacio M.; Mendicino F.; Latagliata R.; Iurlo A.; Branzanti F.; Garibaldi B.; Trawinska M.M.; Cattaneo D.; Krampera M.; Mulas O.; Martino E.A.; Cavo M.; Vianelli N.; Impera S.; Efficace F.; Heidel F.; Breccia M.; Elli E.M.; Palumbo G.A., Ruxolitinib Adherence in Myelofibrosis and Polycythemia Vera: the “RAMP” Italian multicenter prospective study, «ANNALS OF HEMATOLOGY», 2024, 103, pp. 0 - 0 [Scientific article]

Ielo, Claudia; Fazio, Francesca; Rocchi, Serena; Rizzello, Ilaria; Mancuso, Katia; Zamagni, Elena; Cavo, Michele; Petrucci, Maria Teresa, Severe SARS-CoV-2 and subsequent fungal infections after CAR T-cell therapy for relapsed/refractory multiple myeloma: a challenging and happy ending fight, «LEUKEMIA RESEARCH REPORTS», 2024, 21, Article number: 100399 , pp. 1 - 4 [Scientific article]Open Access

Mongiorgi, Sara; De Stefano, Alessia; Ratti, Stefano; Indio, Valentina; Astolfi, Annalisa; Casalin, Irene; Pellagatti, Andrea; Paolini, Stefania; Parisi, Sarah; Cavo, Michele; Pession, Andrea; McCubrey, James A; Suh, Pann-Ghill; Manzoli, Lucia; Boultwood, Jacqueline; Finelli, Carlo; Cocco, Lucio; Follo, Matilde Y, A miRNA screening identifies miR-192-5p as associated with response to azacitidine and lenalidomide therapy in myelodysplastic syndromes, «CLINICAL EPIGENETICS», 2023, 15, Article number: 27 , pp. 1 - 12 [Scientific article]Open Access